These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 17383818

  • 21. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms.
    Han DH, Park DB, Choi TY, Joo SY, Lee MK, Park BR, Nishimura R, Chu CC, Renshaw PF.
    Neuroreport; 2008 Jul 16; 19(11):1155-8. PubMed ID: 18596619
    [Abstract] [Full Text] [Related]

  • 22. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.
    Ho BC, Wassink TH, O'Leary DS, Sheffield VC, Andreasen NC.
    Mol Psychiatry; 2005 Mar 16; 10(3):229, 287-98. PubMed ID: 15668720
    [Abstract] [Full Text] [Related]

  • 23. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis.
    Mata I, Arranz MJ, Staddon S, Lopez-Ilundain JM, Tabares-Seisdedos R, Murray RM.
    Psychiatr Genet; 2006 Oct 16; 16(5):213-6. PubMed ID: 16969277
    [Abstract] [Full Text] [Related]

  • 24. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F, Ollier W, Mayes A, Jackson A, Thacker N, Rabbitt P, Pendleton N, Horan M, Payton A.
    Genes Brain Behav; 2008 Jun 16; 7(4):411-7. PubMed ID: 17973920
    [Abstract] [Full Text] [Related]

  • 25. Differential effect of catechol-O-methyltransferase Val158Met genotype on emotional recognition abilities in healthy men and women.
    Weiss EM, Stadelmann E, Kohler CG, Brensinger CM, Nolan KA, Oberacher H, Parson W, Pitterl F, Niederstätter H, Kemmler G, Hinterhuber H, Marksteiner J.
    J Int Neuropsychol Soc; 2007 Sep 16; 13(5):881-7. PubMed ID: 17517149
    [Abstract] [Full Text] [Related]

  • 26. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
    Baker K, Baldeweg T, Sivagnanasundaram S, Scambler P, Skuse D.
    Biol Psychiatry; 2005 Jul 01; 58(1):23-31. PubMed ID: 15935994
    [Abstract] [Full Text] [Related]

  • 27. The COMT val158met polymorphism and brain morphometry in healthy young adults.
    Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D.
    Neurosci Lett; 2006 Sep 11; 405(1-2):34-9. PubMed ID: 16857316
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, Czerski PM, Hauser J.
    Psychiatry Clin Neurosci; 2006 Feb 11; 60(1):70-6. PubMed ID: 16472361
    [Abstract] [Full Text] [Related]

  • 32. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
    Zinkstok J, van Nimwegen L, van Amelsvoort T, de Haan L, Yusuf MA, Baas F, Linszen D.
    Psychiatry Res; 2008 Jan 15; 157(1-3):1-8. PubMed ID: 17850881
    [Abstract] [Full Text] [Related]

  • 33. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype.
    Tunbridge EM, Weinberger DR, Harrison PJ.
    Mol Psychiatry; 2006 Feb 15; 11(2):116-7. PubMed ID: 16247488
    [No Abstract] [Full Text] [Related]

  • 34. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
    Rakvåg TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F.
    Pain; 2005 Jul 15; 116(1-2):73-8. PubMed ID: 15927391
    [Abstract] [Full Text] [Related]

  • 35. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P, Ortuño F, Zalacain M, Patiño-García A.
    Pharmacogenomics J; 2007 Dec 15; 7(6):418-26. PubMed ID: 17363961
    [Abstract] [Full Text] [Related]

  • 36. COMT val(158)met genotype and smooth pursuit eye movements in schizophrenia.
    Haraldsson HM, Ettinger U, Magnusdottir BB, Sigmundsson T, Sigurdsson E, Ingason A, Petursson H.
    Psychiatry Res; 2009 Sep 30; 169(2):173-5. PubMed ID: 19647329
    [Abstract] [Full Text] [Related]

  • 37. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND, Jayathilake K, Meltzer HY.
    Schizophr Res; 2007 Feb 30; 90(1-3):86-96. PubMed ID: 17123785
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prefrontal dysfunction in schizophrenia controlling for COMT Val158Met genotype and working memory performance.
    Bertolino A, Caforio G, Petruzzella V, Latorre V, Rubino V, Dimalta S, Torraco A, Blasi G, Quartesan R, Mattay VS, Callicott JH, Weinberger DR, Scarabino T.
    Psychiatry Res; 2006 Oct 30; 147(2-3):221-6. PubMed ID: 16952445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.